Viewing Study NCT01744405


Ignite Creation Date: 2025-12-25 @ 3:13 AM
Ignite Modification Date: 2025-12-31 @ 6:31 PM
Study NCT ID: NCT01744405
Status: COMPLETED
Last Update Posted: 2015-03-18
First Post: 2012-12-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease
Sponsor: Hospital de NiƱos R. Gutierrez de Buenos Aires
Organization:

Study Overview

Official Title: Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease
Status: COMPLETED
Status Verified Date: 2015-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: LACTNFX
Brief Summary: The investigators propose to study the transfer of nifurtimox into breastmilk of lactating women who receive the drug for the treatment of Chagas disease.

Breastmilk and blood samples will be obtained from these patients at pre-specified times after they take the clinically indicated medication, and the concentrations in both matrices will be compared to estimate degree of transfer. Estimation of nifurtimox transfer into breastmilk will allow the evaluation of potential degree of exposure of infants breastfed by these women to nifurtimox. This study will help clarify safety of continuing breastfeeding while receiving treatment with nifurtimox for Chagas disease.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: